Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1977 Dec;36(6):751–762. doi: 10.1038/bjc.1977.258

Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.

N Thatcher, M K Palmer, N Gasiunas, D Crowther
PMCID: PMC2025560  PMID: 597473

Abstract

Thirty-eight patients with metastatic melanoma were investigated for lymphocyte function immediately prior to chemo-immunotherapy. The pre-treatment immune tests were compared with normal control values and with response to therapy. The "non-responder" group (but not "responder") had significantly reduced values for lymphocyte, null-cell and E-rosette-cell counts compared with controls. Lymphocytoxicity ( using a Chang target cell) showed the same pattern, with depression of direct and K-cell cytotoxic capacity in non-responders compared with controls. Eight patients were studied sequentially whilst on treatment, and demonstrated considerable change (not statistically significant) in lymphocytotoxicity, an untreated "control" patient showed little variation. "Recall"-antigen skin testing showed no statistically significant difference between the patient groups. The data indicate that "non-T-cell activity" may be associated with response to chemo-immunotherapy.

Full text

PDF
751

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berkelhammer J., Mastrangelo M. J., Laucius J. F., Bodurtha A. J., Prehn R. T. Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donors. Int J Cancer. 1975 Oct 15;16(4):571–578. doi: 10.1002/ijc.2910160407. [DOI] [PubMed] [Google Scholar]
  2. Bianco C., Patrick R., Nussenzweig V. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med. 1970 Oct 1;132(4):702–720. doi: 10.1084/jem.132.4.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fossati G., Colnaghi M. I., Porta G. D., Cascinelli N., Veronesi U. Cellular and humoral immunity against human malignant melanoma. Int J Cancer. 1971 Sep 15;8(2):344–350. doi: 10.1002/ijc.2910080221. [DOI] [PubMed] [Google Scholar]
  4. HOLM G., PERLMANN P., WERNER B. PHYTOHAEMAGGLUTININ-INDUCED CYTOTOXIC ACTION OF NORMAL LYMPHOID CELLS ON CELLS IN TISSUE CULTURE. Nature. 1964 Aug 22;203:841–843. doi: 10.1038/203841a0. [DOI] [PubMed] [Google Scholar]
  5. Harding B., Pudifin D. J., Gotch F., MacLennan I. C. Cytotoxic lymphocytes from rats depleted of thymus processed cells. Nat New Biol. 1971 Jul 21;232(29):80–82. doi: 10.1038/newbio232080a0. [DOI] [PubMed] [Google Scholar]
  6. Heppner G. H., Stolbach L., Byrne M., Cummings F. J., McDonough E., Calabresi P. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma. Int J Cancer. 1973 Mar 15;11(2):245–260. doi: 10.1002/ijc.2910110202. [DOI] [PubMed] [Google Scholar]
  7. Hersey P., Edwards A., Edwards J., Adams E., Milton G. W., Nelson D. S. Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence for "non-specific" killing by activated T-cells. Int J Cancer. 1975 Jul 15;16(1):173–183. doi: 10.1002/ijc.2910160119. [DOI] [PubMed] [Google Scholar]
  8. Holm G., Perlmann P. Quantitative studies on phytohaemagglutinin-induced cytotoxicity by human lymphocytes against homologous cells in tissue culture. Immunology. 1967 May;12(5):525–536. [PMC free article] [PubMed] [Google Scholar]
  9. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jondal M., Pross H. Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer. 1975 Apr 15;15(4):596–605. doi: 10.1002/ijc.2910150409. [DOI] [PubMed] [Google Scholar]
  11. Lay W. H., Mendes N. F., Bianco C., Nussenzweig V. Binding of sheep red blood cells to a large population of human lymphocytes. Nature. 1971 Apr 23;230(5295):531–532. doi: 10.1038/230531a0. [DOI] [PubMed] [Google Scholar]
  12. MacLennan I. C. Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev. 1972;13:67–90. doi: 10.1111/j.1600-065x.1972.tb00060.x. [DOI] [PubMed] [Google Scholar]
  13. MacLennan I. C., Loewi G. Effect of specific antibody to target cells on their specific and non-specific interactions with lymphocytes. Nature. 1968 Sep 7;219(5158):1069–1070. doi: 10.1038/2191069a0. [DOI] [PubMed] [Google Scholar]
  14. Morton D., Eilber F. R., Malmgren R. A., Wood W. C. Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery. 1970 Jul;68(1):158–164. [PubMed] [Google Scholar]
  15. O'Toole C., Stejskal V., Perlmann P., Karlsson M. Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker. J Exp Med. 1974 Mar 1;139(3):457–466. doi: 10.1084/jem.139.3.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Papatestas A. E., Kark A. E. Peripheral lymphocyte counts in breast carcinoma. An index of immune competence. Cancer. 1974 Dec;34(6):2014–2017. doi: 10.1002/1097-0142(197412)34:6<2014::aid-cncr2820340620>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  17. Pavie-Fischer J., Kourilsky F. M., Picard F., Banzet P., Puissant A. Cytotoxicity of lymphocytes from healthy subjects and from melanoma patients against cultured melanoma cells. Clin Exp Immunol. 1975 Sep;21(3):430–441. [PMC free article] [PubMed] [Google Scholar]
  18. Perlmann P., Holm G. Cytotoxic effects of lymphoid cells in vitro. Adv Immunol. 1969;11:117–193. doi: 10.1016/s0065-2776(08)60479-4. [DOI] [PubMed] [Google Scholar]
  19. Peter H. H., Kalden J. R., Seeland P., Diehl V., Eckert G. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells. Clin Exp Immunol. 1975 May;20(2):193–207. [PMC free article] [PubMed] [Google Scholar]
  20. Peter H. H., Pavie-Fischer J., Fridman W. H., Aubert C., Cesarini J. P., Roubin R., Kourilsky F. M. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3). J Immunol. 1975 Aug;115(2):539–548. [PubMed] [Google Scholar]
  21. Riesco A. Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils. Cancer. 1970 Jan;25(1):135–140. doi: 10.1002/1097-0142(197001)25:1<135::aid-cncr2820250120>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  22. Takasugi M., Mickey M. R., Terasaki P. I. Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res. 1973 Nov;33(11):2898–2902. [PubMed] [Google Scholar]
  23. Vanwijck R., Bouillenne C., Malek-Mansour S. Potentiation and arming of lymphocyte mediated immunity by sera from melanoma patients. Eur J Cancer. 1975 Apr;11(4):267–276. doi: 10.1016/0014-2964(75)90007-9. [DOI] [PubMed] [Google Scholar]
  24. Whitehead R. H., Thatcher J., Teasdale C., Roberts G. P., Hughes L. E. T and B lymphocytes in breast cancer stage relationship and abrogation of T-lymphocyte depression by enzyme treatment in vitro. Lancet. 1976 Feb 14;1(7955):330–333. doi: 10.1016/s0140-6736(76)90085-4. [DOI] [PubMed] [Google Scholar]
  25. Wybran J., Fudenberg H. H. Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest. 1973 May;52(5):1026–1032. doi: 10.1172/JCI107267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ziegler J. L., Lewis M. G., Luyombya J. M., Kiryabwire J. W. Immunologic studies in patients with malignant melanoma in Uganda. Br J Cancer. 1969 Dec;23(4):729–734. doi: 10.1038/bjc.1969.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. de Vries J. E., Cornain S., Rumke P. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,. Int J Cancer. 1974 Oct 15;14(4):427–434. doi: 10.1002/ijc.2910140402. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES